<p class="first" id="d871401e190">To validate, in an external cohort, three novel
risk models, including the recently
updated European Randomized Study of Screening for Prostate Cancer (ERSPC) risk calculator,
that combine multiparametric magnetic resonance imaging (mpMRI) and clinical variables
to predict clinically significant prostate cancer (PCa).